Beacon Biosignals
Series BBeacon Biosignals is a privately held company based in United States, founded in 2019. The latest disclosed round is Series B ($103m), dated Oct 07, 2025. Institutional investors on record include General Catalyst, Google Ventures.
United States · EST 2019
What is Beacon Biosignals?
Beacon Biosignals is a privately held company based in United States, founded in 2019. The latest disclosed round is Series B ($103m), dated Oct 07, 2025. Institutional investors on record include General Catalyst, Google Ventures. AI-based EEG analysis and diagnosis platform for healthcare providers. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Beacon Biosignals?
Who invested in Beacon Biosignals?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| General Catalyst | Series B | $103m | Oct 07, 2025 |
| Google Ventures | Series B | $103m | Oct 07, 2025 |
What do founders ask about Beacon Biosignals?
What is Beacon Biosignals?
Beacon Biosignals is a privately held company based in United States, founded in 2019. The latest disclosed round is Series B ($103m), dated Oct 07, 2025. Institutional investors on record include General Catalyst, Google Ventures. AI-based EEG analysis and diagnosis platform for healthcare providers. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Beacon Biosignals's last funding round?
Beacon Biosignals's latest disclosed round is Series B at $103m (Oct 07, 2025).
Who invested in Beacon Biosignals?
Beacon Biosignals has 2 institutional investors on this page, including General Catalyst, Google Ventures.
How does CrackTheDeck cover Beacon Biosignals?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Beacon Biosignals card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.